Adverse events1,246

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,246

Type	Event	Organ system	Group	Affected	At risk
other	Ear discomfort	Ear and labyrinth disorders	Taprenepag 0.0025% (Stage I)	0	9
other	Ear discomfort	Ear and labyrinth disorders	Taprenepag 0.005% (Stage I)	0	9
other	Ear discomfort	Ear and labyrinth disorders	Taprenepag 0.01% (Stage I)	0	9
other	Ear discomfort	Ear and labyrinth disorders	Taprenepag 0.015% (Stage I)	0	10
other	Ear discomfort	Ear and labyrinth disorders	Taprenepag 0.02% (Stage I)	0	9
other	Ear discomfort	Ear and labyrinth disorders	Taprenepag 0.03% (Stage I)	0	9
other	Ear discomfort	Ear and labyrinth disorders	Taprenepag Vehicle (Stage I)	0	12
other	Ear discomfort	Ear and labyrinth disorders	Latanoprost Vehicle and Taprenepag 0.005% (Stage II)	0	35
other	Ear discomfort	Ear and labyrinth disorders	Latanoprost Vehicle and Taprenepag 0.01% (Stage II)	0	36
other	Ear discomfort	Ear and labyrinth disorders	Latanoprost Vehicle and Taprenepag 0.015% (Stage II)	1	36
other	Ear discomfort	Ear and labyrinth disorders	Latanoprost 0.005% and Taprenepag 0.005% (Stage II)	0	36
other	Ear discomfort	Ear and labyrinth disorders	Latanoprost 0.005% and Taprenepag 0.01% (Stage II)	0	36
other	Ear discomfort	Ear and labyrinth disorders	Latanoprost 0.005% and Taprenepag 0.015% (Stage II)	0	36
other	Ear discomfort	Ear and labyrinth disorders	Latanoprost 0.005% and Taprenepag Vehicle (Stage II)	0	35
other	Abnormal sensation in eye, BOTH EYES	Eye disorders	Taprenepag 0.0025% (Stage I)	0	9
other	Abnormal sensation in eye, BOTH EYES	Eye disorders	Taprenepag 0.005% (Stage I)	0	9
other	Abnormal sensation in eye, BOTH EYES	Eye disorders	Taprenepag 0.01% (Stage I)	0	9
other	Abnormal sensation in eye, BOTH EYES	Eye disorders	Taprenepag 0.015% (Stage I)	0	10
other	Abnormal sensation in eye, BOTH EYES	Eye disorders	Taprenepag 0.02% (Stage I)	0	9
other	Abnormal sensation in eye, BOTH EYES	Eye disorders	Taprenepag 0.03% (Stage I)	2	9

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00572455/events

API reference For AI assistants

Adverse events1,246

Sources 3

Read this list from software.